Jushi Holdings (JUSHF) Amortization of Deferred Charges (2021 - 2026)
Jushi Holdings (JUSHF) posted quarterly Amortization of Deferred Charges of $1.1 million for Q2 2026, down 53.56% year-over-year from $2.5 million in Q2 2025, and down 55.92% quarter-over-quarter from $2.6 million in Q1 2026.
Jushi Holdings (JUSHF) Amortization of Deferred Charges (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has reported Amortization of Deferred Charges for 6 consecutive years, with $1.1 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Amortization of Deferred Charges fell 53.56% year-over-year to $1.1 million; the TTM figure through Jun 2026 stood at $8.9 million (up 6.53% YoY), while the FY2025 annual figure was $9.8 million, up 39.4% from the prior year.
- Amortization of Deferred Charges slipped to $1.1 million in Q2 2026 per JUSHF's latest filing, from $2.6 million in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $5.9 million in Q2 2022 and bottomed at $1.1 million in Q2 2026.
- Historically, Amortization of Deferred Charges has averaged $2.6 million across 5 years, with a median of $2.1 million in 2024.
- Annual changes were most pronounced in 2023 — Amortization of Deferred Charges sank 79.8% — and 2024, when it surged 52.96%.
- Jushi Holdings' Amortization of Deferred Charges stood at $3.8 million in 2022, then slumped by 50.63% to $1.9 million in 2023, then rose by 4.59% to $2.0 million in 2024, then surged by 31.48% to $2.6 million in 2025, then tumbled by 56.18% to $1.1 million in 2026.
- Business Quant data shows JUSHF's Amortization of Deferred Charges at $1.1 million in Q2 2026, $2.6 million in Q1 2026, and $2.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Jushi Holdings | 83.87 Mn | 50.54 Mn | 31.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.14 Mn |
| Jun 30, 2026 | 1.14 Mn |
| Mar 31, 2026 | 2.59 Mn |
| Mar 31, 2026 | 2.59 Mn |
| Dec 31, 2025 | 2.61 Mn |
| Dec 31, 2025 | 2.61 Mn |
| Sep 30, 2025 | 2.58 Mn |
| Sep 30, 2025 | 2.58 Mn |
| Jun 30, 2025 | 2.46 Mn |
| Jun 30, 2025 | 2.46 Mn |
| Mar 31, 2025 | 2.17 Mn |
| Mar 31, 2025 | 2.17 Mn |
| Dec 31, 2024 | 1.98 Mn |
| Dec 31, 2024 | 1.98 Mn |
| Sep 30, 2024 | 1.76 Mn |
| Sep 30, 2024 | 1.76 Mn |
| Jun 30, 2024 | 1.81 Mn |
| Jun 30, 2024 | 1.81 Mn |
| Mar 31, 2024 | 1.50 Mn |
| Mar 31, 2024 | 1.50 Mn |